| [1] |
Vanoni F, Lava SAG, Fossali EF, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review[J]. Clin Rev Allerg Immu, 2017, 53(3): 469-476.
|
| [2] |
Zuppa AA, Riccardi R, Frezza S, et al. Neonatal lupus: follow-up in infants with anti-SSA/Ro antibodies and review of the literature[J]. Autoimmun Rev, 2017, 16(4): 427-432.
|
| [3] |
Chang C. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review[J]. J Autoimmun, 2013, 41: 100-110.
|
| [4] |
Hasbún T, Chamlin SL. A 6-week-old boy with annular skin lesions. Neonatal lupus erythematosus[J]. Pediatr Ann, 2014, 43(1): e1-e3.
|
| [5] |
Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies[J]. Arthritis Res Ther, 2012, 14(2): 208.
|
| [6] |
Brito-Zerón P, Izmirly PM, Ramoscasals M, et al. The clinical spectrum of autoimmune congenital heart block[J]. Nat Rev Rheumatol, 2015, 11(5): 301-312.
|
| [7] |
Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association[J]. Circulation, 2014, 129(21): 2183-2242.
|
| [8] |
Brooks P. Fetal manifestations of maternal anti-Ro and La antibodies - more than complete heart block[J]. Australas J Ultrasound Med, 2015, 18(3): 124-128.
|
| [9] |
Saxena A, Izmirly PM, Mendez B, et al. Prevention and treatment in utero of autoimmune-associated congenital heart block[J]. Cardiol Rev, 2014, 22(6): 263-267.
|
| [10] |
Chandler SF, Fynn-Thompson F, Mah DY. Role of cardiac pacing in congenital complete heart block[J]. Expert Rev Cardiovasc Ther, 2017, 15(11): 853-861.
|
| [11] |
Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. Autoimmune congenital heart block: complex and unusual situations[J]. Lupus, 2016, 25(2): 116-128.
|
| [12] |
Chang C. Neonatal autoimmune diseases: a critical review[J]. J Autoimmun, 2012, 38(2-3): J223-J238.
|
| [13] |
Zhou KY, Hua YM. Autoimmune-associated congenital heart block: a new insight in fetal life[J]. Chin Med J, 2017, 130(23): 2863-2871.
|
| [14] |
Ambrosi A, Sonesson SE, Wahren-Herlenius M. Molecular mechanisms of congenital heart block[J]. Exp Cell Res, 2014, 325(1): 2-9.
|
| [15] |
Fayyaz A, Kurien BT, Scofield RH. Autoantibodies in Sjögren′s syndrome[J]. Rheum Dis Clin North Am, 2016, 42(3): 419-434.
|
| [16] |
Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus[J]. J Autoimmunity, 2018, 93: 16-23.
|
| [17] |
Izmirly P, Saxena A, Buyon JP. Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus[J]. Curr Opin Rheumatol, 2017, 29(5): 467-472.
|
| [18] |
Ambrosi A, Dzikaite V, Park J, et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model[J]. Ann Rheum Dis, 2012, 71(3): 448-454.
|
| [19] |
Reed JH, Clancy RM, Lee KH, et al. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus[J]. Arthritis Care Res (Hoboken), 2012, 64(9): 1373-1381.
|
| [20] |
Anami A, Fukushima K, Takasaki Y, et al. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block[J]. Mod Rheumatol, 2013, 23(4): 653-658.
|
| [21] |
Tunks RD, Clowse ME, Miller SG, et al. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents[J]. Am J Obstet Gynecol, 2013, 208(1): 61-64.
|
| [22] |
Tonello M, Hoxha A, Mattia E, et al. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block[J]. Clin Rheumatol, 2017, 36(5): 1155-1160.
|
| [23] |
Tonello M, Ruffatti A, Favaro M, et al. Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients[J]. Lupus Sci Med, 2016, 3(1): e000129.
|
| [24] |
Hunter LE, Simpson JM. Atrioventricular block during fetal life[J]. J Saudi Heart Assoc, 2015, 27(3): 164-178.
|
| [25] |
Madhusudan D, Raju A, Vijaya N. Correlation of maternal autoantibodies with fetal congenital heart block[J]. J Obstet Gynaecol India, 2016, 66(Suppl 1): 112-116.
|
| [26] |
Meisgen S, Östberg T, Salomonsson S, et al. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence[J]. J Intern Med, 2014, 275(6): 640-651.
|
| [27] |
Tang L, Chen B, Ma B, et al. Association between IRF5 polymorphisms and autoimmune diseases: a Meta-analysis[J]. Genet Mol Res, 2014, 13(2): 4473-4485.
|
| [28] |
Lisney AR, Szelinski F, Reiter K, et al. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type Ⅰ interferon signature is a risk factor for the development of autoimmune congenital heart block[J]. Ann Rheum Dis, 2017, 76(8): 1476-1480.
|
| [29] |
张艺凡，牛广华，赵高阳，等. 新生儿狼疮病的研究进展[J]. 临床儿科杂志，2013, 31(10): 994-997.
|
| [30] |
Meisgen S, Tingström J, Skog Andreasson A, et al. Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive women[J]. RMD Open, 2017, 3(2): e000520.
|
| [31] |
Huang YH, Li SC, Huang LH, et al. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease[J]. Oncotarget, 2017, 8(7): 11249-11258.
|
| [32] |
Reed JH, Sim S, Wolin SL, et al. Ro60 requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus[J]. J Immunol, 2013, 191(1): 110-116.
|
| [33] |
Clancy RM, Markham AJ, Buyon JP. Endosomal Toll-like receptors in clinically overt and silent autoimmunity[J]. Immunol Rev, 2016, 269(1): 76-84.
|
| [34] |
Singh AG, Chowdhary VR. Pregnancy-related issues in women with systemic lupus erythematosus[J]. Int J Rheum Dis, 2015, 18(2): 172-181.
|
| [35] |
Leroux M, Desveaux C, Parcevaux M, et al. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study[J]. Lupus, 2015, 24(13): 1384-1391.
|
| [36] |
Karnabi E, Qu Y, Mancarella S, et al. Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice[J]. J Cardiovasc Electrophysiol, 2011, 22(8): 922-930.
|
| [37] |
Strandberg LS, Cui X, Rath A, et al. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts[J]. PLoS One, 2013, 8(9): e72668.
|